News Search Results
Dec 05, 2025, 07:00 ET Seegene abre subsidiária na França para expandir sua presença na Europa
tecnologias de PCR sindrômico em tempo real. Essa experiência foi particularmente importante durante a pandemia da COVID-19, quando a Seegene forneceu mais de 340 milhões de testes de COVID-19 para mais de 100 países em todo o mundo. A característica central da tecnologia de PCR em tempo real sindrômica
More news about: Seegene Inc.
Dec 05, 2025, 04:00 ET A Seegene estabelece uma subsidiária francesa para expandir a pegada europeia
tecnologias de PCR sindrómicas em tempo real. Esta experiência destacou-se, em particular, durante a pandemia de COVID-19, quando a Seegene forneceu mais de 340 milhões de testes COVID-19 a mais de 100 países em todo o mundo. A caraterística principal da tecnologia de PCR sindrómica da Seegene é a capacidade
More news about: Seegene Inc.
Dec 05, 2025, 03:00 ET Seegene zakládá francouzskou dceřinou společnost s cílem rozšířit své působení v Evropě
souvisejícího se syndromickými technologiemi PCR v reálném čase. Tato odbornost byla zvláště zdůrazněna během pandemie COVID-19, kdy společnost Seegene poskytla více než 340 milionů testů na COVID-19 do více než 100 zemí po celém světě. Hlavní předností syndromické technologie PCR v reálném čase společnosti Seegene
More news about: Seegene Inc.
Dec 05, 2025, 03:00 ET Seegene zakladá francúzsku dcérsku spoločnosť s cieľom rozšíriť pôsobnosť na európskom trhu
súvislosti so syndrómovými technológiami PCR v reálom čase. Táto odbornosť sa potvrdila najmä počas pandémie ochorenia COVID-19, keď spoločnosť Seegene poskytla viac ako 340 miliónov testov na COVID-19 viac ako 100 krajinám po celom svete. Základnou vlastnosťou syndrómovej technológie PCR v reálnom čase spoločnosti
More news about: Seegene Inc.
Dec 05, 2025, 03:00 ET Seegene apre una filiale in Francia per rafforzare la propria presenza in Europa
alle tecnologie real-time PCR sindromiche. Questa competenza è apparsa particolarmente evidente durante la pandemia di COVID-19, quando Seegene ha fornito oltre 340 milioni di test COVID-19 in più di 100 paesi in tutto il mondo. La tecnologia PCR sindromica di Seegene consente la rilevazione simultanea di
More news about: Seegene Inc.
Dec 05, 2025, 03:00 ET Seegene otwiera oddział we Francji, aby poszerzyć swój zasięg w Europie
technologii real-time PCR do diagnostyki syndromicznej. To doświadczenie przydało się szczególnie podczas pandemii COVID-19, gdy Seegene dostarczył ponad 340 milionów testów na COVID-19 do przeszło 100 krajów na całym świecie. Technologia real-time PCR do diagnostyki syndromicznej, którą opracowała firma
More news about: Seegene Inc.
Dec 05, 2025, 03:00 ET Seegene établit sa filiale française pour renforcer sa présence en Europe
PCR syndromiques en temps réel. Ces compétences ont été particulièrement mises en évidence lors de la pandémie de COVID-19, lorsque Seegene a fourni plus de 340 millions de tests COVID-19 à plus de 100 pays à travers le monde. La principale caractéristique de la technologie PCR syndromique en temps réel
More news about: Seegene Inc.
Dec 05, 2025, 03:00 ET Seegene crea una filial francesa para ampliar su presencia europea
tecnologías de PCR sindrómica en tiempo real. Esta experiencia se puso especialmente de manifiesto durante la pandemia de COVID-19, cuando Seegene suministró más de 340 millones de pruebas de COVID-19 a más de 100 países de todo el mundo. La característica principal de la tecnología PCR sindrómica en tiempo real
More news about: Seegene Inc.
Dec 05, 2025, 01:00 ET Seegene создает французскую дочернюю компанию для расширения присутствия в Европе
связанного с синдромным подходом к ПЦР-тестированию в реальном времени. Этот опыт был особенно важен во время пандемии COVID-19, когда компания Seegene поставила свыше 340 миллионов тестов на COVID-19 более чем в 100 стран мира. Основной особенностью технологии синдромной диагностики в режиме реального времени
More news about: Seegene Inc.
Dec 04, 2025, 21:00 ET Seegene Mendirikan Anak Usaha di Perancis untuk Memperluas Jangkauan di Eropa
menjalankan litbang (R&D), memproduksi, dan memasarkan teknologi syndromic real-time PCR. Pada masa pandemi Covid-19, Seegene memasok lebih dari 340 juta alat tes Covid-19 ke lebih dari 100 negara. Teknologi syndromic real-time PCR secara serentak mendeteksi 14 patogen yang menimbulkan
More news about: Seegene Inc.
Dec 04, 2025, 16:05 ET Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement
Extends cash runway into first half of 2028, beyond planned completion of ViraxImmune™ US based regulatory study in post-acute sequelae of COVID-19 ("PASC", or long COVID) and submission to the FDA, completion of UK based regulatory study in post-acute infection syndrome (PAIS) and submission
More news about: Virax BioLabs Group Limited
Dec 04, 2025, 09:00 ET VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis
doi: 10.1186/s13613-023-01204-yMorimont, L., et al. (2022). NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study. Biomolecules, 12(8), 1038. doi: 10.3390/biom12081038About
More news about: VolitionRx Limited
Dec 04, 2025, 09:00 ET VolitionRx Limited annonce l'intégration de son test Nu.Q® NETs en tant que biomarqueur innovant dans l'évaluation en vie réelle menée en France sur la détection précoce du sepsis
doi: 10.1186/s13613-023-01204-y Morimont, L., et al. (2022). NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study. Biomolecules, 12(8), 1038. doi: 10.3390/biom12081038
More news about: VolitionRx Limited
Dec 04, 2025, 08:48 ET THEONI Expands in the US Through Placement in Harvest Natural Foods
market."THEONI has experienced double-digit growth every year since its dynamic market entry in 2013, including an 85% increase over the three years of the Covid-19 pandemic. Its proven business model continues to resonate, and 2025 has been no exception in its rapid growth trajectory. THEONI continues to gain
More news about: THEONI
Dec 04, 2025, 08:12 ET UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting
forward-looking statements contained in this press release. Important factors that could result in such differences include: the global spread and impact of COVID-19, changes in general economic, business and competitive conditions, the inability to obtain necessary regulatory approvals or to obtain them on acceptable
More news about: UCB
Dec 04, 2025, 06:05 ET International Superstar YOSHIKI Donates $100,000 for Thailand and Indonesia Flood Relief Immediately Following $100,000 Hong Kong Fire Disaster Donation
humanitarian aid groups. In 2024, he contributed $100,000 to aid victims of Hurricanes Helene and Milton. In 2020, during the COVID-19 pandemic, YOSHIKI donated $100,000 to MusiCares' COVID-19 Relief Fund to support music professionals whose work was canceled. In 2017, YOSHIKI donated $125,000 for Hurricane Harvey
More news about: YOSHIKI
Dec 03, 2025, 16:15 ET Aviat Networks Appoints Andrew C. Schmidt as Chief Financial Officer
served as CFO of Sientra, Inc., a Nasdaq-listed medical aesthetics company, where he successfully guided the company through the challenges of the COVID-19 pandemic and its subsequent sale in 2024.From 2015 to 2020, Mr. Schmidt was CFO of Iteris, Inc., an intelligent transportation technology company
More news about: Aviat Networks, Inc.
Dec 03, 2025, 16:14 ET Mission Rock Residential Charts Its Next Chapter: Longtime Leader Meredith Wright Appointed CEO, Founding CEO Transitions to Advisory Role as Board Chair
industry for her commitment to building culture, mentoring future leaders, and navigating Mission Rock through major market cycles, including the COVID-19 pandemic. Under her leadership, Mission Rock has grown from fewer than a dozen employees to nearly 1,000 team members managing over 160 multifamily
More news about: Mission Rock Residential, LLC
Dec 03, 2025, 13:29 ET NASDAQ: LINE Investors who lost money with Lineage, Inc. (NASDAQ: LINE) shares should contact the Shareholders Foundation in connection with pending Lawsuit
customer demand, as additional cold-storage supply had come on line, Lineage's customers destocked a glut of excessive inventory built up during the COVID-19 pandemic, and Lineage's customers shifted to maintaining leaner cold-storage inventories on a go-forward basis in response to changed consumer trends,
More news about: Shareholders Foundation, Inc.
Dec 03, 2025, 12:59 ET U.S. FDA approves expanded indication for Lilly's Jaypirca (pirtobrutinib), the first and only non-covalent (reversible) BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK inhibitor
pneumonia (14%), COVID-19 (4.7%), musculoskeletal pain (3.9%), hemorrhage (2.3%), pleural effusion (2.3%), and sepsis (2.3%) occurring in ≥2% of patients. Fatal ARs within 28 days of last dose occurred in 7% of patients, most commonly due to infections (4.7%), including COVID-19 (3.1% of all patients).Dose
More news about: Eli Lilly and Company
Dec 03, 2025, 10:16 ET The Authority™ Unveils World's First Grading Chip™ Alongside Upper Deck's 2024-25 The Cup Release
the pandemic, the Company's security and safety division worked with NIAID biodefense to be the first group in the world to inactivate SARS-CoV-2 (COVID-19) using optical energy. Since 2012, Dynamics has also developed collectible platforms and technologies that have managed over 500 million collectibles.
More news about: The Authority™
Dec 03, 2025, 08:01 ET Artera Secures $65M Growth Investment and Reaches $100M CARR
defined the market through distinct eras of change. The first era began with foundational text messaging; the market then rapidly accelerated during the COVID-19 pandemic, and then ushered in the era of AI-driven automation. Today, patient communications has entered its most transformative phase: the evolution
More news about: Artera
Dec 03, 2025, 07:34 ET Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
collaboration with Emory University (ADJUST Center and ELIAD) to support U.S. regulatory and potential commercial plans in post-acute sequelae of COVID-19 (PASC, or Long COVID).ImmuneSelect RUO expansion: Continued development of the ImmuneSelect research-use-only ("RUO") portfolio of
More news about: Virax BioLabs Group Limited
Dec 03, 2025, 07:30 ET BTQ Technologies Announces Research Coverage from Leading Digital Asset Research Firm Delphi Digital on Bitcoin Quantum, the Quantum-Safe Bitcoin Network Developed by BTQ
conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays
More news about: BTQ Technologies Corp.
Dec 03, 2025, 04:00 ET U.S. Economy to Slow Through Early 2026, While California Navigates a Two-Speed Recovery
major U.S. economic forecasting group to call the recession of 2001 and, in March 2020, it was the first to declare that the recession caused by the COVID-19 pandemic had already begun.
More news about: UCLA Anderson Forecast